Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues. 1989

L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
Department of Medicinal Chemistry, Smith Kline & French Laboratories, Swedeland, Pennsylvania 19406.

In an attempt to identify a soluble oncodazole analogue that could be easily formulated, a series of substituted oncodazoles was synthesized and evaluated for tubulin binding affinity, in vitro cytotoxicity against cultured mouse B-16 cells, and ability to prolong lifespan at the maximally tolerated dose in the P388 mouse leukemia model. Biological evaluation of all the isomeric methyloncodazoles demonstrated the thiophene 4'-position to be the only site of significant bulk tolerance, although substitution of this position with polar or charged functional groups abolished biological activity. Simple esters of the 4'-carboxymethyloncodazole were shown to have enhanced antitumor activity and tubulin binding affinity relative to oncodazole. Despite a failure of this study to identify a water-soluble oncodazole with antitumor activity, the structure-activity relationship developed led to a derivative with enhanced activity in the P388 leukemia model and facilitated the preparation of a biologically active photolabile analogue.

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015739 Nocodazole Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules. NSC-238159,Oncodazole,R-17934,R17934,NSC 238159,NSC238159,R 17934
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
March 2009, ChemMedChem,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
April 1979, Life sciences,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
March 2003, The Journal of antibiotics,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
December 2007, The Journal of organic chemistry,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
September 2021, ChemMedChem,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
March 1996, Journal of medicinal chemistry,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
January 2004, Journal of peptide science : an official publication of the European Peptide Society,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
January 2014, Nucleosides, nucleotides & nucleic acids,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
September 2001, Bioorganic & medicinal chemistry letters,
L I Kruse, and D L Ladd, and P B Harrsch, and F L McCabe, and S M Mong, and L Faucette, and R Johnson
September 2023, International journal of molecular sciences,
Copied contents to your clipboard!